Evidence map›Paper›PMID 38156273›Full record

ArticleFrontiers in neuroscience2023

Pharmacological interventions for lipid transport disorders.

Aaron M Neiman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Update on Genetic Chorea.Current neurology and neuroscience reports · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Aaron M NeimanDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, United States.
Stony Brook University · US

Funding

Equipment supplement for grant R01 GM072540 Assembly and Function of the Yeast Spore Wall.R01GM072540 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI NEIMAN, AARON M · 2005 to 2025
$7.1M
REGULATION OF THE SECRETORY PATHWAY IN YEASTR01GM062184 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI NEIMAN, AARON M · 2001 to 2009
$2.5M
Mechanisms of de novo membrane assemblyR01GM145606 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Aaron M Neiman · 2023 to 2026
$1.3M
NIGMS NIH HHS R01 GM062184NIGMS NIH HHS R01 GM072540NIGMS NIH HHS R01 GM145606
6 · The paper itself

Abstract

The recent discovery that defects in inter-organelle lipid transport are at the heart of several neurological and neurodegenerative disorders raises the challenge of identifying therapeutic strategies to correct lipid transport defects. This perspective highlights two potential strategies suggested by the study of lipid transport in budding yeast. In the first approach, small molecules are proposed that enhance the lipid transfer activity of

Indexed as

lipid transportmembrane contact site (MCS)neuroacanthocytosisParkinson’s diseaseproteolysis-targeting chimeric (PROTAC) moleculeVPS13 genes

Identifiers

PMID38156273
PMCPMC10752963
OpenAlexW4389733222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.